Mechanistic Target of Rapamycin (serine/threonine Kinase) (mTOR) (C-Term) Peptide
mTOR
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all MTOR (mTOR) products
- MTOR (mTOR) (Mechanistic Target of Rapamycin (serine/threonine Kinase) (mTOR))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- PLLNWRLMDT NTKGNKRSRT RTDSYSAGQS VEILDGVELG EPAHKKTGTT
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-MTOR Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MTOR (mTOR) (Mechanistic Target of Rapamycin (serine/threonine Kinase) (mTOR))
- Background
-
The protein encoded by this gene belongs to a family of phosphatidylinositol kinase-related kinases. These kinases mediate cellular responses to stresses such as DNA damage and nutrient deprivation. This protein acts as the target for the cell-cycle arrest and immunosuppressive effects of the FKBP12-rapamycin complex. The ANGPTL7 gene is located in an intron of this gene.
Alias Symbols: SKS, FRAP, FRAP1, FRAP2, RAFT1, RAPT1
Protein Size: 161 - Gene ID
- 2475
- NCBI Accession
- NP_004949
- UniProt
- B1AKQ2
-
You are here:
